Literature DB >> 8517793

Protective immunity of Hantaan virus nucleocapsid and envelope protein studied using baculovirus-expressed proteins.

K Yoshimatsu1, Y C Yoo, R Yoshida, C Ishihara, I Azuma, J Arikawa.   

Abstract

Recombinant Hantaan virus nucleocapsid protein (rNP) and recombinant envelope (rEnv) proteins were prepared using a baculovirus expression system to examine the role of Hantaan virus structural proteins in protective immunity. Passive transfer of spleen cells from mice immunized with rNP conferred partial protection or prolongation of time to death from fatal Hantaan virus infection in suckling mice which were challenged with Hantaan virus at 40 LD50 (survival rate: 43%) or 4 LD50 (survival rate: 43%). The T cell-enriched fraction protected one mouse from lethal infection but the B cell-enriched fraction had no such effect on fatal HTN infection. The protective effects of the antibody against HTN challenge were examined by passive immunization. The monoclonal antibody ECO 2 directed to NP also conferred partial survival and significant difference in time to death. Although rEnv antigen failed to induce neutralizing antibody, both immune spleen cells and immune serum to rEnv conferred partial protection upon suckling mice. These results indicate that both nucleocapsid and envelope proteins of Hantaan virus were responsible for induction of cell mediated protective immunity. Vero E 6 cells infected with Hantaan virus expressed envelope protein on the surface, as determined by flow cytometry. However, there was only negligible expression of nucleocapsid protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8517793     DOI: 10.1007/BF01309667

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  28 in total

1.  Expression of H-2I region-restricted cytolytic activity by an Lyt-2+ influenza virus-specific T lymphocyte clone.

Authors:  L A Morrison; V L Braciale; T J Braciale
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

2.  Induction and activity of class II-restricted, Lyt-2+ cytolytic T lymphocytes specific for the influenza H5 hemagglutinin.

Authors:  C E Hioe; V S Hinshaw
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

3.  Functional heterogeneity among herpes simplex virus-specific human CD4+ T cells.

Authors:  M Yasukawa; A Inatsuki; T Horiuchi; Y Kobayashi
Journal:  J Immunol       Date:  1991-02-15       Impact factor: 5.422

4.  Cross-reactive immunity among different serotypes of virus causing haemorrhagic fever with renal syndrome.

Authors:  H Asada; K Balachandra; M Tamura; K Kondo; K Yamanishi
Journal:  J Gen Virol       Date:  1989-04       Impact factor: 3.891

5.  Preparation of complement fixation antigen of Chlamydia psittaci grown in tissue culture by treatment with beta-propiolactone.

Authors:  N Chiba; I Takashima; J Arikawa; N Hashimoto
Journal:  Microbiol Immunol       Date:  1984       Impact factor: 1.955

6.  Monoclonal antibodies to three strains of hantaviruses: Hantaan, R22, and Puumala.

Authors:  S L Ruo; A Sanchez; L H Elliott; L S Brammer; J B McCormick; S P Fisher-Hoch
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

7.  Cell-mediated immunity to virus causing haemorrhagic fever with renal syndrome: generation of cytotoxic T lymphocytes.

Authors:  H Asada; M Tamura; K Kondo; Y Dohi; K Yamanishi
Journal:  J Gen Virol       Date:  1988-09       Impact factor: 3.891

8.  Expression of human immunodeficiency virus type 1 (HIV-1) gag antigens on the surface of a cell line persistently infected with HIV-1 that highly expresses HIV-1 antigens.

Authors:  K Ikuta; C Morita; S Miyake; T Ito; M Okabayashi; K Sano; M Nakai; K Hirai; S Kato
Journal:  Virology       Date:  1989-06       Impact factor: 3.616

9.  Immune spleen cell-mediated protection against fatal Hantaan virus infection in infant mice.

Authors:  T Nakamura; R Yanagihara; C J Gibbs; D C Gajdusek
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

10.  The targeting of CD4+ T lymphocytes to a B cell lymphoma. A comparison of anti-CD3-anti-idiotype antibody conjugates and antigen-anti-idiotype antibody conjugates.

Authors:  M Gravelle; A Ochi
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

View more
  13 in total

1.  Wild-type Puumala hantavirus infection induces cytokines, C-reactive protein, creatinine, and nitric oxide in cynomolgus macaques.

Authors:  J Klingström; A Plyusnin; A Vaheri; A Lundkvist
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Pathogenicity of Hantaan virus in newborn mice: genetic reassortant study demonstrating that a single amino acid change in glycoprotein G1 is related to virulence.

Authors:  H Ebihara; K Yoshimatsu; M Ogino; K Araki; Y Ami; H Kariwa; I Takashima; D Li; J Arikawa
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

Review 3.  Human pathogenic hantaviruses and prevention of infection.

Authors:  Detlev H Krüger; Günther Schönrich; Boris Klempa
Journal:  Hum Vaccin       Date:  2011-06-01

4.  Phylogenetic analysis of Puumala virus subtype Bavaria, characterization and diagnostic use of its recombinant nucleocapsid protein.

Authors:  Marc Mertens; Eveline Kindler; Petra Emmerich; Jutta Esser; Christiane Wagner-Wiening; Roman Wölfel; Rasa Petraityte-Burneikiene; Jonas Schmidt-Chanasit; Aurelija Zvirbliene; Martin H Groschup; Gerhard Dobler; Martin Pfeffer; Gerald Heckel; Rainer G Ulrich; Sandra S Essbauer
Journal:  Virus Genes       Date:  2011-05-20       Impact factor: 2.332

5.  Humoral response in Toscana virus acute neurologic disease investigated by viral-protein-specific immunoassays.

Authors:  F Magurano; L Nicoletti
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

6.  Cross-protection against challenge with Puumala virus after immunization with nucleocapsid proteins from different hantaviruses.

Authors:  Cristina de Carvalho Nicacio; Marcelo Gonzalez Della Valle; Paula Padula; Ewa Björling; Alexander Plyusnin; Ake Lundkvist
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

7.  Characterization of human antibody responses to four corners hantavirus infections among patients with hantavirus pulmonary syndrome.

Authors:  S Jenison; T Yamada; C Morris; B Anderson; N Torrez-Martinez; N Keller; B Hjelle
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

8.  Development and Characterization of Monoclonal Antibodies Directed Against the Nucleoprotein of Heartland Virus.

Authors:  Amanda E Calvert; Aaron C Brault
Journal:  Am J Trop Med Hyg       Date:  2015-10-26       Impact factor: 2.345

9.  Expression of immunogenic Puumala virus nucleocapsid protein in transgenic tobacco and potato plants.

Authors:  R Kehm; N J Jakob; T M Welzel; E Tobiasch; O Viczian; S Jock; K Geider; S Süle; G Darai
Journal:  Virus Genes       Date:  2001-01       Impact factor: 2.198

10.  Critical epitopes in the nucleocapsid protein of SFTS virus recognized by a panel of SFTS patients derived human monoclonal antibodies.

Authors:  Li Yu; Li Zhang; Lina Sun; Jing Lu; Wei Wu; Chuan Li; Quanfu Zhang; Fushun Zhang; Cong Jin; Xianjun Wang; Zhenqiang Bi; Dexin Li; Mifang Liang
Journal:  PLoS One       Date:  2012-06-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.